Press Releases
Novavax & Serum Institute of India to manufacture COVID-19 Vaccine
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced an amendment to its existing agreement with Serum Institute of...
Press Releases
RDIF and Dr. Reddy’s to cooperate on clinical trials and supply of 100 million doses of Sputnik V vaccine to India
The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and Dr. Reddy’s Laboratories Ltd. (Dr. Reddy’s), a global pharmaceutical company headquartered out of...
Packaging & Labelling
FedEx to Transform Package Tracking with SenseAware ID, the Latest Innovation in FedEx Sensor Technology
FedEx to Transform Package Tracking with SenseAware ID, the Latest Innovation in FedEx Sensor Technology SenseAwareID to Provide Enhanced Package Visibility for COVID-19 Vaccine...
News
Oxford University resume Covid-19 vaccine trial
Oxford University on Saturday, 13th Sep. 2020 announced resuming coronavirus vaccine trials, the study which was suspended following a reported side-effect in a UK...
News
DCGI nod to Serum-Oxford covid-19 vaccine for phase 2, 3 clinical trials in India
India's top drug regulator-- Drugs Controller General of India (DCGI) has granted permission to Serum Institute of India (SII) to conduct phase 2 and...
News
Serum Institute of India COVID-19 Vaccine advances to trial for phase-III on 1500 Indian patients
Serum institute has completed phase II-B3 trails and will commence phase-III trail after clearances. The third phase trail will be tested on 1500 patients...
News
Paradigm4 launches Revels Single Cell app for analysing large-scale data sets
Paradigm4, specialist in scientific data management and scalable computation, has launched its REVEAL: Single CellTM app to offer biopharmaceutical developers the ability to break...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read